Cumbre Pharmaceuticals and TB Alliance Announce Partnership to Develop New Agents for Tuberculosis Therapy
New TB Drugs Urgently Needed to Replace Treatments Designed in the 1960s Dallas, Texas/ New York, September 27, 2006 —
News
News
TB Alliance Applauds Innovative, International Effort to Fund New Drugs
FOR IMMEDIATE RELEASE Global Alliance for TB Drug Development Applauds Innovative, International Effort to Fund New Drugs ‘UNITAID’ Announces Funding
News
New Drugs for TB – Past Time to Deliver
Tuberculosis (TB) is the leading infectious killer of people with HIV/AIDS. In some countries of sub-Saharan Africa, more than 75
News
Extreme Tuberculosis
Tuberculosis is outrunning us. In the last few months, 53 patients in the South African province of KwaZulu-Natal were found
News
Extreme TB strain threatens HIV victims worldwide
South Africa outbreak may prove impossible to contain. An outbreak of virulent and very drug-resistant tuberculosis in South Africans with
News
TB Alliance and Bayer Win Award for Innovative Licensing of Drug Being Tested for the Treatment of Tuberculosis
Licensing Executive Society Awards the “Deal of Distinction” Prize for Top Licensing Agreement in the Industry-University-Government Category NEW YORK CITY
News
Request for Proposals: Preclinical Drug Combinations Study
The TB Alliance is sponsoring a systematic, preclinical study looking into various drug combinations for the treatment of tuberculosis. The
News
TB Alliance Applauds Action on XDR-TB; Says More Resources are Needed
TB Alliance Applauds Actions by Health Leaders on XDR-TB and Says More Resources are Needed to Speed Development of New
News
Dr. Maria C. Freire Meets with Peruvian Health Ministers, Past and Present
On a visit this week to Peru, Dr. Maria C. Freire, CEO and President of the TB Alliance, was honored
News
TB and HIV/AIDS on the Leonard Lopate Show
As part of its “underreported” news series, public radio’s Leonard Lopate Show today explored TB’s impact on the HIV/AIDS epidemic,